TrkC plays an essential role in breast tumor growth and metastasis

Carcinogenesis

Volumn 31, Issue 11, 2010, Pages 1939-1947

  Jin, Wook ^a   Kim, Gyoung Mi ^a   Kim, Min Soo ^a   Lim, Mi Hee ^a   Yun, Chohee ^b   Jeong, Joon ^c   Nam, Jeong Seok ^a   Kim, Seong Jin ^a,b  

^a Gachon University College of Medicine   (South Korea)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; RAS MITOGEN ACTIVATED PROTEIN KINASE; TROPOMYOSIN; TROPOMYOSIN RELATED KINASE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST METASTASIS; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; LUNG METASTASIS; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; RECEPTOR, TRKC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 78149274357     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq180     Document Type: Article

References (46)

1. Bothwell, M. (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci., 18, 223-253.
2. Chao, M.V. et al. (2002) Neurotrophins: to cleave or not to cleave. Neuron, 33, 9-12.
3. Marchetti, D. et al. (1993) Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int. J. Cancer, 55, 692-699.
4. McGregor, L.M. et al. (1999) Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. Proc. Natl Acad. Sci. USA, 96, 4540-4545.
5. Nakagawara, A. (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett., 169, 107-114.
6. Nicholson, K.M. et al. (2003) Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines. Breast Cancer Res. Treat., 81, 117-128.
7. Ricci, A. et al. (2001) Neurotrophins and neurotrophin receptors in human lung cancer. Am. J. Respir. Cell Mol. Biol., 25, 439-446.
8. Kogner, P. et al. (1993) Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res., 53, 2044-2050.
9. Nakagawara, A. et al. (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol., 14, 759-767.
10. Grotzer, M.A. et al. (2000) TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J. Clin. Oncol., 18, 1027-1035.
11. Segal, R.A. et al. (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc. Natl Acad. Sci. USA, 91, 12867-12871.
12. Yamashiro, D.J. et al. (1997) Expression and function of Trk-C in favourable human neuroblastomas. Eur. J. Cancer, 33, 2054-2057.
13. Dalal, R. et al. (1997) Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate. Mol. Cell. Endocrinol., 134, 15-22.
14. Weeraratna, A.T. et al. (2000) Rational basis for Trk inhibition therapy for prostate cancer. Prostate, 45, 140-148.
15. Sakamoto, Y. et al. (2001) Expression of Trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma. Oncol. Rep., 8, 477-484.
16. Douma, S. et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature, 430, 1034-1039.
17. Chen-Tsai, C.P. et al. (2004) Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas. Dermatol. Surg., 30, 1009-1016.
18. Hisaoka, M. et al. (2002) Gene expression of TrkC (NTRK3) in human soft tissue tumours. J. Pathol., 197, 661-667.
19. Satoh, F. et al. (2001) Autocrine expression of neurotrophins and their receptors in prostate cancer. Int. J. Urol., 8, S28-S34.
20. Bardelli, A. et al. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science, 300, 949.
21. Wood, L.D. et al. (2006) Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum. Mutat., 27, 1060-1.
22. Blasco-Gutierrez, M.J. et al. (2007) TrkC: a new predictive marker in breast cancer? Cancer Invest., 25, 405-410.
23. Calatozzolo, C. et al. (2007) Expression of cannabinoid receptors and neurotrophins in human gliomas. Neurol. Sci., 28, 304-310.
24. Aslakson, C.J. et al. (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res., 52, 1399-1405.
25. Miknyoczki, S.J. et al. (1999) The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma. Clin. Cancer Res., 5, 2205-2212.
26. Knezevich, S.R. et al. (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet., 18, 184-187.
27. Tognon, C. et al. (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell, 2, 367-376.
28. Song, G. et al. (2005) The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med., 9, 59-71.
29. Zhao, X. et al. (2004) Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation-and 14-3-3-dependent and -independent mechanisms. Biochem. J., 378, 839-849.
30. Gao, D. et al. (2009) Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat. Cell Biol., 11, 397-408.
31. Yang, J. et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939.
32. Shawver, L.K. et al. (2002) Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell, 1, 117-123.
33. Ruggeri, B.A. et al. (1999) Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models. Curr. Med. Chem., 6, 845-857.
34. Hempstead, B.L. et al. (1992) Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron, 9, 883-896.
35. Pierotti, M.A. et al. (2006) Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Lett., 232, 90-98.
36. Eguchi, M. et al. (1999) Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood, 93, 1355-1363.
37. Wai, D.H. et al. (2000) The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene, 19, 906-915.
38. Brodeur, G.M. et al. (1997) Expression of TrkA, TrkB and TrkC in human neuroblastomas. J. Neurooncol., 31, 49-55.
39. Guate, J.L. et al. (1999) Expression of p75(LNGFR) and Trk neurotrophin receptors in normal and neoplastic human prostate. BJU Int., 84, 495-502.
40. Rickert, C.H. (2004) Prognosis-related molecular markers in pediatric central nervous system tumors. J. Neuropathol. Exp. Neurol., 63, 1211-1224.
41. Ryden, M. et al. (1996) Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br. J. Cancer, 74, 773-779.
42. Hoek, K. et al. (2004) Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res., 64, 5270-5282.
43. Maestro, R. et al. (1999) Twist is a potential oncogene that inhibits apoptosis. Genes Dev., 13, 2207-2217.
44. Rosivatz, E. et al. (2002) Differential expression of the epithelialmesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol., 161, 1881-1891.
45. van Doorn, R. et al. (2004) Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res., 64, 5578-5586.
46. Barnabe-Heider, F. et al. (2003) Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J. Neurosci., 23, 5149-5160.